Skip to main content
Clinical Trials/NCT07232992
NCT07232992
Completed
Not Applicable

The Effectiveness of the Serratus Posterior Superior Intercostal Plane Block on Postoperative Analgesia and Recovery in Open-heart Surgery: A Prospective, Double-blind, Randomized Controlled Trial.

Bursa City Hospital1 site in 1 country70 target enrollmentStarted: January 15, 2026Last updated:

Overview

Phase
Not Applicable
Status
Completed
Sponsor
Bursa City Hospital
Enrollment
70
Locations
1
Primary Endpoint
opioid consumption

Overview

Brief Summary

Postoperative pain following open-heart surgery is a significant challenge that may negatively affect recovery and overall clinical outcomes. Due to the risks and contraindications associated with neuraxial techniques, the use of fascial plane blocks has increased in recent years. In patients undergoing cardiac surgery, the location and intensity of postoperative pain may vary daily. However, during the first 24 hours, pain is typically most pronounced at the median sternotomy incision site and at the insertion sites of chest, mediastinal, and pleural drains.

Current postoperative analgesia practices in open-heart surgery commonly include multimodal regimens using simple analgesics such as paracetamol and nonsteroidal anti-inflammatory drugs, combined with a regional anesthesia technique such as the parasternal block. The Serratus Posterior Superior Intercostal Plane Block (SPSIPB) is an interfascial plane block that involves the injection of local anesthetic between the serratus posterior superior and intercostal muscles, providing wide dermatomal coverage from the upper cervical to lower thoracic regions. Although the technique has been used successfully in individual clinical cases, no randomized controlled studies have been conducted to evaluate its efficacy in open-heart surgery.

This study aims to compare the postoperative analgesic effectiveness of the SPSIPB with a combination of parasternal block and local anesthetic infiltration at drain insertion sites in patients undergoing open-heart surgery.

Detailed Description

Postoperative pain following open-heart surgery is a significant challenge that may negatively affect recovery and overall clinical outcomes. Due to the risks and contraindications associated with neuraxial techniques, the use of fascial plane blocks has increased in recent years. In patients undergoing cardiac surgery, the location and intensity of postoperative pain may vary daily. However, during the first 24 hours, pain is typically most pronounced at the median sternotomy incision site and at the insertion sites of chest, mediastinal, and pleural drains.

Current postoperative analgesia practices in open-heart surgery commonly include multimodal regimens using simple analgesics such as paracetamol and nonsteroidal anti-inflammatory drugs, combined with a regional anesthesia technique such as the parasternal block. The Serratus Posterior Superior Intercostal Plane Block (SPSIPB) is an interfascial plane block that involves the injection of local anesthetic between the serratus posterior superior and intercostal muscles, providing wide dermatomal coverage from the upper cervical to lower thoracic regions. Although the technique has been used successfully in individual clinical cases, no randomized controlled studies have been conducted to evaluate its efficacy in open-heart surgery.

This study aims to compare the postoperative analgesic effectiveness of the SPSIPB with a combination of parasternal block and local anesthetic infiltration at drain insertion sites in patients undergoing open-heart surgery.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Double (Participant, Outcomes Assessor)

Eligibility Criteria

Ages
18 Years to 85 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Patients aged 18-85 years with ASA physical status II-III undergoing elective open-heart surgery.

Exclusion Criteria

  • Patients who do not consent to participate in the study
  • Patients with coagulopathy
  • History of allergy or toxicity to local anesthetics
  • Patients with hepatic or renal failure
  • Patients with uncontrolled diabetes mellitus
  • Patients with uncontrolled hypertension
  • Mentally disabled patients
  • Patients receiving chronic pain therapy (opioid use)
  • Use of antidepressant medication
  • Presence of neuropathic pain

Arms & Interventions

Group Control

Active Comparator

Parasternal block and local infiltration at the drain insertion site.

Intervention: Parasternal blocks (Other)

Group Control

Active Comparator

Parasternal block and local infiltration at the drain insertion site.

Intervention: Local Infiltration (Other)

Group SPSIPB

Active Comparator

It will be administered bilaterally before the induction of general anesthesia.

Intervention: SPSIPB blcok (Other)

Outcomes

Primary Outcomes

opioid consumption

Time Frame: 0, 2, 4, 8, 16 and 24 hours

Fentanyl will be prepared at a concentration of 10 µg/mL, and patient-controlled analgesia (PCA) will be administered without a basal infusion, using a lock-out interval of 20 minutes and a bolus dose of 20 µg.

Secondary Outcomes

  • Postoperative pain scores (Numerical rating scale) (0-meaning "no pain" to 10-meaning "worst pain imaginable")(0, 2, 4, 8, 16 and 24 hours)
  • Global recovery scoring system (patient satisfaction scale)- QoR-15(The quality of recovery will be evaluated out of a total of 150 points according to the QoR-15 test to be applied at the portoperative 24th hour.)

Investigators

Sponsor
Bursa City Hospital
Sponsor Class
Other Gov
Responsible Party
Principal Investigator
Principal Investigator

eralp çevikkalp

assoc prof

Bursa City Hospital

Study Sites (1)

Loading locations...

Similar Trials